Inventor · disambiguated record
Michael D. Loberg
Also filed as: LOBERG MICHAEL · LOBERG MICHAEL D · LOBERG MICHAEL DEWEY
9 granted patents·2 pending applications·472 citations·filing 1975–2009
91Inventor score
Top patents by PatentIndex Score
11 records- 0195US6635273B1Methods of treating vascular diseases characterized by nitric oxide insufficiencyUNIV BOSTON·Filed 2000·Granted Oct 21, 2003·102 cites·33 claims
- 0291US7537785B2Composition for treating vascular diseases characterized by nitric oxide insufficiencyNITROMED INC·Filed 2003·Granted May 26, 2009·44 cites·20 claims
- 0390US7235237B2Methods of treating vascular diseases characterized by nitric oxide insufficiencyNITROMED INC·Filed 2001·Granted Jun 26, 2007·37 cites·17 claims
- 0489US4017596ARadiopharmaceutical chelates and method of external imagingRESEARCH CORP·Filed 1975·Granted Apr 12, 1977·71 cites·13 claims
- 0585US4585009AStrontium-rubidium infusion pump with in-line dosimetrySQUIBB & SONS INC·Filed 1983·Granted Apr 29, 1986·169 cites·8 claims
- 0681US4406877A82 Rb Generating method and eluentSQUIBB & SONS INC·Filed 1980·Granted Sep 27, 1983·33 cites·12 claims
- 0774US7708989B2Methods of treating vascular diseases characterized by nitric oxide insufficiencyNITROMED INC·Filed 2003·Granted May 4, 2010·4 cites·10 claims
- 0870US2010068267A1Compositions for treating vascular diseases characterized by nitric oxide insufficiencyNITROMED INC·Filed 2009·Application pending·0 cites
- 0953US7556824B2Transdermal patch composition for treating vascular diseases characterized by nitric oxide insufficiencyNITROMED INC·Filed 2003·Granted Jul 7, 2009·0 cites·8 claims
- 1051US4418208AN-Substituted iminodiacetic acidsSQUIBB & SONS INC·Filed 1982·Granted Nov 29, 1983·12 cites·9 claims
- 1145US2008293724A1Methods Using Hydralazine Compounds and Isosorbide Dinitrate or Isosorbide MononitrateNITROMED INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael D. Loberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →